Cargando…
Renin–angiotensin–aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are known to impact the functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association between chronic therapy with these medications and infection risk remains...
Autores principales: | Sandhu, Alexander T, Kohsaka, Shun, Lin, Shoutzu, Woo, Christopher Y, Goldstein, Mary K., Heidenreich, Paul A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196226/ https://www.ncbi.nlm.nih.gov/pubmed/34126079 http://dx.doi.org/10.1016/j.ahj.2021.06.004 |
Ejemplares similares
-
Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020) -
Medical therapy for patients with recent-onset heart failure with reduced ejection fraction during the COVID-19 pandemic: Insights from the Veteran's affairs healthcare system
por: Sandhu, Alexander T., et al.
Publicado: (2022) -
Association of Diagnostic Coding‐Based Frailty and Outcomes in Patients With Heart Failure: A Report From the Veterans Affairs Health System
por: Kohsaka, Shun, et al.
Publicado: (2020) -
Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia
por: Kohsaka, Shun, et al.
Publicado: (2022) -
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)